Synthesis and antiprotozoal activity of nitazoxanide–N-methylbenzimidazole hybrids

A series of a novel hybrid compounds between nitazoxanide and N-methylbenzimidazole were synthesized starting from the corresponding N-methyl-2-nitroanilines. The new hybrid compounds (1–13) were evaluated in vitro against Giardia intestinalis, Entamoeba histolytica, Trichomonas vaginalis. NTZ, MTZ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2013-12, Vol.23 (24), p.6838-6841
Hauptverfasser: Soria-Arteche, Olivia, Hernández-Campos, Alicia, Yépez-Mulia, Lilián, Trejo-Soto, Pedro Josué, Hernández-Luis, Francisco, Gres-Molina, Jorge, Maldonado, Luis A., Castillo, Rafael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6841
container_issue 24
container_start_page 6838
container_title Bioorganic & medicinal chemistry letters
container_volume 23
creator Soria-Arteche, Olivia
Hernández-Campos, Alicia
Yépez-Mulia, Lilián
Trejo-Soto, Pedro Josué
Hernández-Luis, Francisco
Gres-Molina, Jorge
Maldonado, Luis A.
Castillo, Rafael
description A series of a novel hybrid compounds between nitazoxanide and N-methylbenzimidazole were synthesized starting from the corresponding N-methyl-2-nitroanilines. The new hybrid compounds (1–13) were evaluated in vitro against Giardia intestinalis, Entamoeba histolytica, Trichomonas vaginalis. NTZ, MTZ and ABZ were used as drug standards. Experimental evaluations revealed all of the new compounds (1–13) were active and showed strong activity against the three protozoa, particularly with E. histolytica where the IC50 values ranged between 3 and 69nM. Overall, compounds 2, 5, 7, 8, 9, 11 and 12 stood out with values lower than 87nM for all three protozoa, comparatively better than the reference drugs.
doi_str_mv 10.1016/j.bmcl.2013.10.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1464501018</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X13011992</els_id><sourcerecordid>1464501018</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-bf9904723caf7e30bfc2a3f5f95dd7045793de44be4837bc31d84197ee00f6423</originalsourceid><addsrcrecordid>eNp9kMFO3DAQhq0KVLa0L9BDmyOXLOPY2SQSF4RKi4TgwK7Um-XY465XSQy2FzV74h36hjwJjpZy5DAaaeabX6OPkK8U5hTo4nQzb3vVzQugLA3mQOkHMqN8wXPGoTwgM2gWkNcN_31EPoWwAaAcOP9IjgpOa1ZymJHl3TjENQYbMjnoVNHeexfdzskukyraRxvHzJlssFHu3F85WI3PT_9u8h7jeuxaHHa2tzrtOszWY-utDp_JoZFdwC-v_ZisLn8sL37l17c_ry7Or3PFaoh5a5oGeFUwJU2FDFqjCslMaZpS6wp4WTVMI-ct8ppVrWJU15w2FSKAWfCCHZOTfW56-WGLIYreBoVdJwd02yAmFyUkV3VCiz2qvAvBoxH33vbSj4KCmGyKjZhsisnmNEs209G31_xt26N-O_mvLwHf94CRTsg_3gaxuksJZVLNiopNxNmewOTh0aIXQVkcFGrrUUWhnX3vgxelRZGO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1464501018</pqid></control><display><type>article</type><title>Synthesis and antiprotozoal activity of nitazoxanide–N-methylbenzimidazole hybrids</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Soria-Arteche, Olivia ; Hernández-Campos, Alicia ; Yépez-Mulia, Lilián ; Trejo-Soto, Pedro Josué ; Hernández-Luis, Francisco ; Gres-Molina, Jorge ; Maldonado, Luis A. ; Castillo, Rafael</creator><creatorcontrib>Soria-Arteche, Olivia ; Hernández-Campos, Alicia ; Yépez-Mulia, Lilián ; Trejo-Soto, Pedro Josué ; Hernández-Luis, Francisco ; Gres-Molina, Jorge ; Maldonado, Luis A. ; Castillo, Rafael</creatorcontrib><description>A series of a novel hybrid compounds between nitazoxanide and N-methylbenzimidazole were synthesized starting from the corresponding N-methyl-2-nitroanilines. The new hybrid compounds (1–13) were evaluated in vitro against Giardia intestinalis, Entamoeba histolytica, Trichomonas vaginalis. NTZ, MTZ and ABZ were used as drug standards. Experimental evaluations revealed all of the new compounds (1–13) were active and showed strong activity against the three protozoa, particularly with E. histolytica where the IC50 values ranged between 3 and 69nM. Overall, compounds 2, 5, 7, 8, 9, 11 and 12 stood out with values lower than 87nM for all three protozoa, comparatively better than the reference drugs.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2013.10.011</identifier><identifier>PMID: 24183540</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antiprotozoal Agents - chemical synthesis ; Antiprotozoal Agents - chemistry ; Antiprotozoal Agents - pharmacology ; Benzimidazole ; Benzimidazoles - chemical synthesis ; Benzimidazoles - chemistry ; Benzimidazoles - pharmacology ; chemistry ; Drug Design ; drugs ; Entamoeba histolytica ; Entamoeba histolytica - drug effects ; Eukaryota - drug effects ; Giardia intestinalis ; Giardia lamblia ; Giardia lamblia - drug effects ; Hybrid compounds ; inhibitory concentration 50 ; Nitazoxanide ; Thiazoles - chemistry ; Trichomonas vaginalis ; Trichomonas vaginalis - drug effects</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2013-12, Vol.23 (24), p.6838-6841</ispartof><rights>2013 Elsevier Ltd</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-bf9904723caf7e30bfc2a3f5f95dd7045793de44be4837bc31d84197ee00f6423</citedby><cites>FETCH-LOGICAL-c380t-bf9904723caf7e30bfc2a3f5f95dd7045793de44be4837bc31d84197ee00f6423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmcl.2013.10.011$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24183540$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soria-Arteche, Olivia</creatorcontrib><creatorcontrib>Hernández-Campos, Alicia</creatorcontrib><creatorcontrib>Yépez-Mulia, Lilián</creatorcontrib><creatorcontrib>Trejo-Soto, Pedro Josué</creatorcontrib><creatorcontrib>Hernández-Luis, Francisco</creatorcontrib><creatorcontrib>Gres-Molina, Jorge</creatorcontrib><creatorcontrib>Maldonado, Luis A.</creatorcontrib><creatorcontrib>Castillo, Rafael</creatorcontrib><title>Synthesis and antiprotozoal activity of nitazoxanide–N-methylbenzimidazole hybrids</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A series of a novel hybrid compounds between nitazoxanide and N-methylbenzimidazole were synthesized starting from the corresponding N-methyl-2-nitroanilines. The new hybrid compounds (1–13) were evaluated in vitro against Giardia intestinalis, Entamoeba histolytica, Trichomonas vaginalis. NTZ, MTZ and ABZ were used as drug standards. Experimental evaluations revealed all of the new compounds (1–13) were active and showed strong activity against the three protozoa, particularly with E. histolytica where the IC50 values ranged between 3 and 69nM. Overall, compounds 2, 5, 7, 8, 9, 11 and 12 stood out with values lower than 87nM for all three protozoa, comparatively better than the reference drugs.</description><subject>Antiprotozoal Agents - chemical synthesis</subject><subject>Antiprotozoal Agents - chemistry</subject><subject>Antiprotozoal Agents - pharmacology</subject><subject>Benzimidazole</subject><subject>Benzimidazoles - chemical synthesis</subject><subject>Benzimidazoles - chemistry</subject><subject>Benzimidazoles - pharmacology</subject><subject>chemistry</subject><subject>Drug Design</subject><subject>drugs</subject><subject>Entamoeba histolytica</subject><subject>Entamoeba histolytica - drug effects</subject><subject>Eukaryota - drug effects</subject><subject>Giardia intestinalis</subject><subject>Giardia lamblia</subject><subject>Giardia lamblia - drug effects</subject><subject>Hybrid compounds</subject><subject>inhibitory concentration 50</subject><subject>Nitazoxanide</subject><subject>Thiazoles - chemistry</subject><subject>Trichomonas vaginalis</subject><subject>Trichomonas vaginalis - drug effects</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFO3DAQhq0KVLa0L9BDmyOXLOPY2SQSF4RKi4TgwK7Um-XY465XSQy2FzV74h36hjwJjpZy5DAaaeabX6OPkK8U5hTo4nQzb3vVzQugLA3mQOkHMqN8wXPGoTwgM2gWkNcN_31EPoWwAaAcOP9IjgpOa1ZymJHl3TjENQYbMjnoVNHeexfdzskukyraRxvHzJlssFHu3F85WI3PT_9u8h7jeuxaHHa2tzrtOszWY-utDp_JoZFdwC-v_ZisLn8sL37l17c_ry7Or3PFaoh5a5oGeFUwJU2FDFqjCslMaZpS6wp4WTVMI-ct8ppVrWJU15w2FSKAWfCCHZOTfW56-WGLIYreBoVdJwd02yAmFyUkV3VCiz2qvAvBoxH33vbSj4KCmGyKjZhsisnmNEs209G31_xt26N-O_mvLwHf94CRTsg_3gaxuksJZVLNiopNxNmewOTh0aIXQVkcFGrrUUWhnX3vgxelRZGO</recordid><startdate>20131215</startdate><enddate>20131215</enddate><creator>Soria-Arteche, Olivia</creator><creator>Hernández-Campos, Alicia</creator><creator>Yépez-Mulia, Lilián</creator><creator>Trejo-Soto, Pedro Josué</creator><creator>Hernández-Luis, Francisco</creator><creator>Gres-Molina, Jorge</creator><creator>Maldonado, Luis A.</creator><creator>Castillo, Rafael</creator><general>Elsevier Ltd</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131215</creationdate><title>Synthesis and antiprotozoal activity of nitazoxanide–N-methylbenzimidazole hybrids</title><author>Soria-Arteche, Olivia ; Hernández-Campos, Alicia ; Yépez-Mulia, Lilián ; Trejo-Soto, Pedro Josué ; Hernández-Luis, Francisco ; Gres-Molina, Jorge ; Maldonado, Luis A. ; Castillo, Rafael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-bf9904723caf7e30bfc2a3f5f95dd7045793de44be4837bc31d84197ee00f6423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antiprotozoal Agents - chemical synthesis</topic><topic>Antiprotozoal Agents - chemistry</topic><topic>Antiprotozoal Agents - pharmacology</topic><topic>Benzimidazole</topic><topic>Benzimidazoles - chemical synthesis</topic><topic>Benzimidazoles - chemistry</topic><topic>Benzimidazoles - pharmacology</topic><topic>chemistry</topic><topic>Drug Design</topic><topic>drugs</topic><topic>Entamoeba histolytica</topic><topic>Entamoeba histolytica - drug effects</topic><topic>Eukaryota - drug effects</topic><topic>Giardia intestinalis</topic><topic>Giardia lamblia</topic><topic>Giardia lamblia - drug effects</topic><topic>Hybrid compounds</topic><topic>inhibitory concentration 50</topic><topic>Nitazoxanide</topic><topic>Thiazoles - chemistry</topic><topic>Trichomonas vaginalis</topic><topic>Trichomonas vaginalis - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soria-Arteche, Olivia</creatorcontrib><creatorcontrib>Hernández-Campos, Alicia</creatorcontrib><creatorcontrib>Yépez-Mulia, Lilián</creatorcontrib><creatorcontrib>Trejo-Soto, Pedro Josué</creatorcontrib><creatorcontrib>Hernández-Luis, Francisco</creatorcontrib><creatorcontrib>Gres-Molina, Jorge</creatorcontrib><creatorcontrib>Maldonado, Luis A.</creatorcontrib><creatorcontrib>Castillo, Rafael</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soria-Arteche, Olivia</au><au>Hernández-Campos, Alicia</au><au>Yépez-Mulia, Lilián</au><au>Trejo-Soto, Pedro Josué</au><au>Hernández-Luis, Francisco</au><au>Gres-Molina, Jorge</au><au>Maldonado, Luis A.</au><au>Castillo, Rafael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and antiprotozoal activity of nitazoxanide–N-methylbenzimidazole hybrids</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2013-12-15</date><risdate>2013</risdate><volume>23</volume><issue>24</issue><spage>6838</spage><epage>6841</epage><pages>6838-6841</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>A series of a novel hybrid compounds between nitazoxanide and N-methylbenzimidazole were synthesized starting from the corresponding N-methyl-2-nitroanilines. The new hybrid compounds (1–13) were evaluated in vitro against Giardia intestinalis, Entamoeba histolytica, Trichomonas vaginalis. NTZ, MTZ and ABZ were used as drug standards. Experimental evaluations revealed all of the new compounds (1–13) were active and showed strong activity against the three protozoa, particularly with E. histolytica where the IC50 values ranged between 3 and 69nM. Overall, compounds 2, 5, 7, 8, 9, 11 and 12 stood out with values lower than 87nM for all three protozoa, comparatively better than the reference drugs.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>24183540</pmid><doi>10.1016/j.bmcl.2013.10.011</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2013-12, Vol.23 (24), p.6838-6841
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_1464501018
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Antiprotozoal Agents - chemical synthesis
Antiprotozoal Agents - chemistry
Antiprotozoal Agents - pharmacology
Benzimidazole
Benzimidazoles - chemical synthesis
Benzimidazoles - chemistry
Benzimidazoles - pharmacology
chemistry
Drug Design
drugs
Entamoeba histolytica
Entamoeba histolytica - drug effects
Eukaryota - drug effects
Giardia intestinalis
Giardia lamblia
Giardia lamblia - drug effects
Hybrid compounds
inhibitory concentration 50
Nitazoxanide
Thiazoles - chemistry
Trichomonas vaginalis
Trichomonas vaginalis - drug effects
title Synthesis and antiprotozoal activity of nitazoxanide–N-methylbenzimidazole hybrids
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T22%3A05%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20antiprotozoal%20activity%20of%20nitazoxanide%E2%80%93N-methylbenzimidazole%20hybrids&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Soria-Arteche,%20Olivia&rft.date=2013-12-15&rft.volume=23&rft.issue=24&rft.spage=6838&rft.epage=6841&rft.pages=6838-6841&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2013.10.011&rft_dat=%3Cproquest_cross%3E1464501018%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1464501018&rft_id=info:pmid/24183540&rft_els_id=S0960894X13011992&rfr_iscdi=true